Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1256564

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1256564

Global Cancer Patient Registry Software Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 94 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Cancer Patient Registry Software Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Patient Registry Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Cloud-based
    • 1.2.3 On-premise
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Patient Registry Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals and Medical Practices
    • 1.3.3 Private Payer
    • 1.3.4 Research Center
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Patient Registry Software Market Perspective (2018-2029)
  • 2.2 Global Cancer Patient Registry Software Growth Trends by Region
    • 2.2.1 Cancer Patient Registry Software Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Cancer Patient Registry Software Historic Market Size by Region (2018-2023)
    • 2.2.3 Cancer Patient Registry Software Forecasted Market Size by Region (2024-2029)
  • 2.3 Cancer Patient Registry Software Market Dynamics
    • 2.3.1 Cancer Patient Registry Software Industry Trends
    • 2.3.2 Cancer Patient Registry Software Market Drivers
    • 2.3.3 Cancer Patient Registry Software Market Challenges
    • 2.3.4 Cancer Patient Registry Software Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Cancer Patient Registry Software by Players
    • 3.1.1 Global Cancer Patient Registry Software Revenue by Players (2018-2023)
    • 3.1.2 Global Cancer Patient Registry Software Revenue Market Share by Players (2018-2023)
  • 3.2 Global Cancer Patient Registry Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Cancer Patient Registry Software, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Cancer Patient Registry Software Market Concentration Ratio
    • 3.4.1 Global Cancer Patient Registry Software Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Patient Registry Software Revenue in 2022
  • 3.5 Global Key Players of Cancer Patient Registry Software Head office and Area Served
  • 3.6 Global Key Players of Cancer Patient Registry Software, Product and Application
  • 3.7 Global Key Players of Cancer Patient Registry Software, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Patient Registry Software Breakdown Data by Type

  • 4.1 Global Cancer Patient Registry Software Historic Market Size by Type (2018-2023)
  • 4.2 Global Cancer Patient Registry Software Forecasted Market Size by Type (2024-2029)

5 Cancer Patient Registry Software Breakdown Data by Application

  • 5.1 Global Cancer Patient Registry Software Historic Market Size by Application (2018-2023)
  • 5.2 Global Cancer Patient Registry Software Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Cancer Patient Registry Software Market Size (2018-2029)
  • 6.2 North America Cancer Patient Registry Software Market Size by Type
    • 6.2.1 North America Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 6.2.2 North America Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 6.2.3 North America Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 6.3 North America Cancer Patient Registry Software Market Size by Application
    • 6.3.1 North America Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 6.3.2 North America Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 6.3.3 North America Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 6.4 North America Cancer Patient Registry Software Market Size by Country
    • 6.4.1 North America Cancer Patient Registry Software Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Cancer Patient Registry Software Market Size by Country (2018-2023)
    • 6.4.3 North America Cancer Patient Registry Software Market Size by Country (2024-2029)
    • 6.4.4 U.S.
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Cancer Patient Registry Software Market Size (2018-2029)
  • 7.2 Europe Cancer Patient Registry Software Market Size by Type
    • 7.2.1 Europe Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 7.2.2 Europe Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 7.2.3 Europe Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 7.3 Europe Cancer Patient Registry Software Market Size by Application
    • 7.3.1 Europe Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 7.3.2 Europe Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 7.3.3 Europe Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 7.4 Europe Cancer Patient Registry Software Market Size by Country
    • 7.4.1 Europe Cancer Patient Registry Software Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Cancer Patient Registry Software Market Size by Country (2018-2023)
    • 7.4.3 Europe Cancer Patient Registry Software Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Cancer Patient Registry Software Market Size (2018-2029)
  • 8.2 China Cancer Patient Registry Software Market Size by Type
    • 8.2.1 China Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 8.2.2 China Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 8.2.3 China Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 8.3 China Cancer Patient Registry Software Market Size by Application
    • 8.3.1 China Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 8.3.2 China Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 8.3.3 China Cancer Patient Registry Software Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Cancer Patient Registry Software Market Size (2018-2029)
  • 9.2 Asia Cancer Patient Registry Software Market Size by Type
    • 9.2.1 Asia Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 9.2.2 Asia Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 9.2.3 Asia Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 9.3 Asia Cancer Patient Registry Software Market Size by Application
    • 9.3.1 Asia Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 9.3.2 Asia Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 9.3.3 Asia Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 9.4 Asia Cancer Patient Registry Software Market Size by Region
    • 9.4.1 Asia Cancer Patient Registry Software Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Cancer Patient Registry Software Market Size by Region (2018-2023)
    • 9.4.3 Asia Cancer Patient Registry Software Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Elekta
    • 11.1.1 Elekta Company Details
    • 11.1.2 Elekta Business Overview
    • 11.1.3 Elekta Cancer Patient Registry Software Introduction
    • 11.1.4 Elekta Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.1.5 Elekta Recent Developments
  • 11.2 Electronic Registry Systems
    • 11.2.1 Electronic Registry Systems Company Details
    • 11.2.2 Electronic Registry Systems Business Overview
    • 11.2.3 Electronic Registry Systems Cancer Patient Registry Software Introduction
    • 11.2.4 Electronic Registry Systems Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.2.5 Electronic Registry Systems Recent Developments
  • 11.3 C/Net Solutions
    • 11.3.1 C/Net Solutions Company Details
    • 11.3.2 C/Net Solutions Business Overview
    • 11.3.3 C/Net Solutions Cancer Patient Registry Software Introduction
    • 11.3.4 C/Net Solutions Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.3.5 C/Net Solutions Recent Developments
  • 11.4 Rocky Mountain Cancer Data Systems
    • 11.4.1 Rocky Mountain Cancer Data Systems Company Details
    • 11.4.2 Rocky Mountain Cancer Data Systems Business Overview
    • 11.4.3 Rocky Mountain Cancer Data Systems Cancer Patient Registry Software Introduction
    • 11.4.4 Rocky Mountain Cancer Data Systems Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.4.5 Rocky Mountain Cancer Data Systems Recent Developments
  • 11.5 McKesson Corporation
    • 11.5.1 McKesson Corporation Company Details
    • 11.5.2 McKesson Corporation Business Overview
    • 11.5.3 McKesson Corporation Cancer Patient Registry Software Introduction
    • 11.5.4 McKesson Corporation Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.5.5 McKesson Corporation Recent Developments
  • 11.6 Onco
    • 11.6.1 Onco Company Details
    • 11.6.2 Onco Business Overview
    • 11.6.3 Onco Cancer Patient Registry Software Introduction
    • 11.6.4 Onco Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.6.5 Onco Recent Developments
  • 11.7 Ordinal Data
    • 11.7.1 Ordinal Data Company Details
    • 11.7.2 Ordinal Data Business Overview
    • 11.7.3 Ordinal Data Cancer Patient Registry Software Introduction
    • 11.7.4 Ordinal Data Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.7.5 Ordinal Data Recent Developments
  • 11.8 Conduent
    • 11.8.1 Conduent Company Details
    • 11.8.2 Conduent Business Overview
    • 11.8.3 Conduent Cancer Patient Registry Software Introduction
    • 11.8.4 Conduent Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.8.5 Conduent Recent Developments
  • 11.9 HimagineSolutions
    • 11.9.1 HimagineSolutions Company Details
    • 11.9.2 HimagineSolutions Business Overview
    • 11.9.3 HimagineSolutions Cancer Patient Registry Software Introduction
    • 11.9.4 HimagineSolutions Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.9.5 HimagineSolutions Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Patient Registry Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Cloud-based
    • 1.2.3 On-premise
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Patient Registry Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals and Medical Practices
    • 1.3.3 Private Payer
    • 1.3.4 Research Center
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Patient Registry Software Market Perspective (2018-2029)
  • 2.2 Global Cancer Patient Registry Software Growth Trends by Region
    • 2.2.1 Cancer Patient Registry Software Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Cancer Patient Registry Software Historic Market Size by Region (2018-2023)
    • 2.2.3 Cancer Patient Registry Software Forecasted Market Size by Region (2024-2029)
  • 2.3 Cancer Patient Registry Software Market Dynamics
    • 2.3.1 Cancer Patient Registry Software Industry Trends
    • 2.3.2 Cancer Patient Registry Software Market Drivers
    • 2.3.3 Cancer Patient Registry Software Market Challenges
    • 2.3.4 Cancer Patient Registry Software Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Cancer Patient Registry Software by Players
    • 3.1.1 Global Cancer Patient Registry Software Revenue by Players (2018-2023)
    • 3.1.2 Global Cancer Patient Registry Software Revenue Market Share by Players (2018-2023)
  • 3.2 Global Cancer Patient Registry Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Cancer Patient Registry Software, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Cancer Patient Registry Software Market Concentration Ratio
    • 3.4.1 Global Cancer Patient Registry Software Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Patient Registry Software Revenue in 2022
  • 3.5 Global Key Players of Cancer Patient Registry Software Head office and Area Served
  • 3.6 Global Key Players of Cancer Patient Registry Software, Product and Application
  • 3.7 Global Key Players of Cancer Patient Registry Software, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Patient Registry Software Breakdown Data by Type

  • 4.1 Global Cancer Patient Registry Software Historic Market Size by Type (2018-2023)
  • 4.2 Global Cancer Patient Registry Software Forecasted Market Size by Type (2024-2029)

5 Cancer Patient Registry Software Breakdown Data by Application

  • 5.1 Global Cancer Patient Registry Software Historic Market Size by Application (2018-2023)
  • 5.2 Global Cancer Patient Registry Software Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Cancer Patient Registry Software Market Size (2018-2029)
  • 6.2 North America Cancer Patient Registry Software Market Size by Type
    • 6.2.1 North America Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 6.2.2 North America Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 6.2.3 North America Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 6.3 North America Cancer Patient Registry Software Market Size by Application
    • 6.3.1 North America Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 6.3.2 North America Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 6.3.3 North America Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 6.4 North America Cancer Patient Registry Software Market Size by Country
    • 6.4.1 North America Cancer Patient Registry Software Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Cancer Patient Registry Software Market Size by Country (2018-2023)
    • 6.4.3 North America Cancer Patient Registry Software Market Size by Country (2024-2029)
    • 6.4.4 U.S.
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Cancer Patient Registry Software Market Size (2018-2029)
  • 7.2 Europe Cancer Patient Registry Software Market Size by Type
    • 7.2.1 Europe Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 7.2.2 Europe Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 7.2.3 Europe Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 7.3 Europe Cancer Patient Registry Software Market Size by Application
    • 7.3.1 Europe Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 7.3.2 Europe Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 7.3.3 Europe Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 7.4 Europe Cancer Patient Registry Software Market Size by Country
    • 7.4.1 Europe Cancer Patient Registry Software Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Cancer Patient Registry Software Market Size by Country (2018-2023)
    • 7.4.3 Europe Cancer Patient Registry Software Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Cancer Patient Registry Software Market Size (2018-2029)
  • 8.2 China Cancer Patient Registry Software Market Size by Type
    • 8.2.1 China Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 8.2.2 China Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 8.2.3 China Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 8.3 China Cancer Patient Registry Software Market Size by Application
    • 8.3.1 China Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 8.3.2 China Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 8.3.3 China Cancer Patient Registry Software Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Cancer Patient Registry Software Market Size (2018-2029)
  • 9.2 Asia Cancer Patient Registry Software Market Size by Type
    • 9.2.1 Asia Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 9.2.2 Asia Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 9.2.3 Asia Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 9.3 Asia Cancer Patient Registry Software Market Size by Application
    • 9.3.1 Asia Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 9.3.2 Asia Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 9.3.3 Asia Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 9.4 Asia Cancer Patient Registry Software Market Size by Region
    • 9.4.1 Asia Cancer Patient Registry Software Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Cancer Patient Registry Software Market Size by Region (2018-2023)
    • 9.4.3 Asia Cancer Patient Registry Software Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Elekta
    • 11.1.1 Elekta Company Details
    • 11.1.2 Elekta Business Overview
    • 11.1.3 Elekta Cancer Patient Registry Software Introduction
    • 11.1.4 Elekta Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.1.5 Elekta Recent Developments
  • 11.2 Electronic Registry Systems
    • 11.2.1 Electronic Registry Systems Company Details
    • 11.2.2 Electronic Registry Systems Business Overview
    • 11.2.3 Electronic Registry Systems Cancer Patient Registry Software Introduction
    • 11.2.4 Electronic Registry Systems Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.2.5 Electronic Registry Systems Recent Developments
  • 11.3 C/Net Solutions
    • 11.3.1 C/Net Solutions Company Details
    • 11.3.2 C/Net Solutions Business Overview
    • 11.3.3 C/Net Solutions Cancer Patient Registry Software Introduction
    • 11.3.4 C/Net Solutions Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.3.5 C/Net Solutions Recent Developments
  • 11.4 Rocky Mountain Cancer Data Systems
    • 11.4.1 Rocky Mountain Cancer Data Systems Company Details
    • 11.4.2 Rocky Mountain Cancer Data Systems Business Overview
    • 11.4.3 Rocky Mountain Cancer Data Systems Cancer Patient Registry Software Introduction
    • 11.4.4 Rocky Mountain Cancer Data Systems Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.4.5 Rocky Mountain Cancer Data Systems Recent Developments
  • 11.5 McKesson Corporation
    • 11.5.1 McKesson Corporation Company Details
    • 11.5.2 McKesson Corporation Business Overview
    • 11.5.3 McKesson Corporation Cancer Patient Registry Software Introduction
    • 11.5.4 McKesson Corporation Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.5.5 McKesson Corporation Recent Developments
  • 11.6 Onco
    • 11.6.1 Onco Company Details
    • 11.6.2 Onco Business Overview
    • 11.6.3 Onco Cancer Patient Registry Software Introduction
    • 11.6.4 Onco Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.6.5 Onco Recent Developments
  • 11.7 Ordinal Data
    • 11.7.1 Ordinal Data Company Details
    • 11.7.2 Ordinal Data Business Overview
    • 11.7.3 Ordinal Data Cancer Patient Registry Software Introduction
    • 11.7.4 Ordinal Data Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.7.5 Ordinal Data Recent Developments
  • 11.8 Conduent
    • 11.8.1 Conduent Company Details
    • 11.8.2 Conduent Business Overview
    • 11.8.3 Conduent Cancer Patient Registry Software Introduction
    • 11.8.4 Conduent Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.8.5 Conduent Recent Developments
  • 11.9 HimagineSolutions
    • 11.9.1 HimagineSolutions Company Details
    • 11.9.2 HimagineSolutions Business Overview
    • 11.9.3 HimagineSolutions Cancer Patient Registry Software Introduction
    • 11.9.4 HimagineSolutions Revenue in Cancer Patient Registry Software Business (2018-2023)
    • 11.9.5 HimagineSolutions Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

  • Table 1. Global Cancer Patient Registry Software Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Cloud-based
  • Table 3. Key Players of On-premise
  • Table 4. Global Cancer Patient Registry Software Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 5. Global Cancer Patient Registry Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Cancer Patient Registry Software Market Size by Region (2018-2023) & (US$ Million)
  • Table 7. Global Cancer Patient Registry Software Market Share by Region (2018-2023)
  • Table 8. Global Cancer Patient Registry Software Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 9. Global Cancer Patient Registry Software Market Share by Region (2024-2029)
  • Table 10. Cancer Patient Registry Software Market Trends
  • Table 11. Cancer Patient Registry Software Market Drivers
  • Table 12. Cancer Patient Registry Software Market Challenges
  • Table 13. Cancer Patient Registry Software Market Restraints
  • Table 14. Global Cancer Patient Registry Software Revenue by Players (2018-2023) & (US$ Million)
  • Table 15. Global Cancer Patient Registry Software Revenue Share by Players (2018-2023)
  • Table 16. Global Top Cancer Patient Registry Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Patient Registry Software as of 2022)
  • Table 17. Global Cancer Patient Registry Software Industry Ranking 2021 VS 2022 VS 2023
  • Table 18. Global 5 Largest Players Market Share by Cancer Patient Registry Software Revenue (CR5 and HHI) & (2018-2023)
  • Table 19. Global Key Players of Cancer Patient Registry Software, Headquarters and Area Served
  • Table 20. Global Key Players of Cancer Patient Registry Software, Product and Application
  • Table 21. Global Key Players of Cancer Patient Registry Software, Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Cancer Patient Registry Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 24. Global Cancer Patient Registry Software Revenue Market Share by Type (2018-2023)
  • Table 25. Global Cancer Patient Registry Software Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 26. Global Cancer Patient Registry Software Revenue Market Share by Type (2024-2029)
  • Table 27. Global Cancer Patient Registry Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 28. Global Cancer Patient Registry Software Revenue Share by Application (2018-2023)
  • Table 29. Global Cancer Patient Registry Software Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 30. Global Cancer Patient Registry Software Revenue Share by Application (2024-2029)
  • Table 31. North America Cancer Patient Registry Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 32. North America Cancer Patient Registry Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 33. North America Cancer Patient Registry Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 34. North America Cancer Patient Registry Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 35. North America Cancer Patient Registry Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 36. North America Cancer Patient Registry Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 37. North America Cancer Patient Registry Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 38. Europe Cancer Patient Registry Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 39. Europe Cancer Patient Registry Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 40. Europe Cancer Patient Registry Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 41. Europe Cancer Patient Registry Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 42. Europe Cancer Patient Registry Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 43. Europe Cancer Patient Registry Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 44. Europe Cancer Patient Registry Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 45. China Cancer Patient Registry Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 46. China Cancer Patient Registry Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 47. China Cancer Patient Registry Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 48. China Cancer Patient Registry Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 49. Asia Cancer Patient Registry Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 50. Asia Cancer Patient Registry Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 51. Asia Cancer Patient Registry Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 52. Asia Cancer Patient Registry Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 53. Asia Cancer Patient Registry Software Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 54. Asia Cancer Patient Registry Software Market Size by Region (2018-2023) & (US$ Million)
  • Table 55. Asia Cancer Patient Registry Software Market Size by Region (2024-2029) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type (2018-2023) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Type (2024-2029) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Application (2024-2029) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Cancer Patient Registry Software Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 61. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country (2018-2023) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size by Country (2024-2029) & (US$ Million)
  • Table 63. Elekta Company Details
  • Table 64. Elekta Business Overview
  • Table 65. Elekta Cancer Patient Registry Software Product
  • Table 66. Elekta Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 67. Elekta Recent Developments
  • Table 68. Electronic Registry Systems Company Details
  • Table 69. Electronic Registry Systems Business Overview
  • Table 70. Electronic Registry Systems Cancer Patient Registry Software Product
  • Table 71. Electronic Registry Systems Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 72. Electronic Registry Systems Recent Developments
  • Table 73. C/Net Solutions Company Details
  • Table 74. C/Net Solutions Business Overview
  • Table 75. C/Net Solutions Cancer Patient Registry Software Product
  • Table 76. C/Net Solutions Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 77. C/Net Solutions Recent Developments
  • Table 78. Rocky Mountain Cancer Data Systems Company Details
  • Table 79. Rocky Mountain Cancer Data Systems Business Overview
  • Table 80. Rocky Mountain Cancer Data Systems Cancer Patient Registry Software Product
  • Table 81. Rocky Mountain Cancer Data Systems Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 82. Rocky Mountain Cancer Data Systems Recent Developments
  • Table 83. McKesson Corporation Company Details
  • Table 84. McKesson Corporation Business Overview
  • Table 85. McKesson Corporation Cancer Patient Registry Software Product
  • Table 86. McKesson Corporation Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 87. McKesson Corporation Recent Developments
  • Table 88. Onco Company Details
  • Table 89. Onco Business Overview
  • Table 90. Onco Cancer Patient Registry Software Product
  • Table 91. Onco Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 92. Onco Recent Developments
  • Table 93. Ordinal Data Company Details
  • Table 94. Ordinal Data Business Overview
  • Table 95. Ordinal Data Cancer Patient Registry Software Product
  • Table 96. Ordinal Data Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 97. Ordinal Data Recent Developments
  • Table 98. Conduent Company Details
  • Table 99. Conduent Business Overview
  • Table 100. Conduent Cancer Patient Registry Software Product
  • Table 101. Conduent Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 102. Conduent Recent Developments
  • Table 103. HimagineSolutions Company Details
  • Table 104. HimagineSolutions Business Overview
  • Table 105. HimagineSolutions Cancer Patient Registry Software Product
  • Table 106. HimagineSolutions Revenue in Cancer Patient Registry Software Business (2018-2023) & (US$ Million)
  • Table 107. HimagineSolutions Recent Developments
  • Table 108. Research Programs/Design for This Report
  • Table 109. Key Data Information from Secondary Sources
  • Table 110. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cancer Patient Registry Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Cancer Patient Registry Software Market Share by Type: 2022 VS 2029
  • Figure 3. Cloud-based Features
  • Figure 4. On-premise Features
  • Figure 5. Global Cancer Patient Registry Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 6. Global Cancer Patient Registry Software Market Share by Application: 2022 VS 2029
  • Figure 7. Hospitals and Medical Practices Case Studies
  • Figure 8. Private Payer Case Studies
  • Figure 9. Research Center Case Studies
  • Figure 10. Others Case Studies
  • Figure 11. Cancer Patient Registry Software Report Years Considered
  • Figure 12. Global Cancer Patient Registry Software Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 13. Global Cancer Patient Registry Software Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 14. Global Cancer Patient Registry Software Market Share by Region: 2022 VS 2029
  • Figure 15. Global Cancer Patient Registry Software Market Share by Players in 2022
  • Figure 16. Global Top Cancer Patient Registry Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Patient Registry Software as of 2022)
  • Figure 17. The Top 10 and 5 Players Market Share by Cancer Patient Registry Software Revenue in 2022
  • Figure 18. North America Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. North America Cancer Patient Registry Software Market Share by Type (2018-2029)
  • Figure 20. North America Cancer Patient Registry Software Market Share by Application (2018-2029)
  • Figure 21. North America Cancer Patient Registry Software Market Share by Country (2018-2029)
  • Figure 22. United States Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Cancer Patient Registry Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 25. Europe Cancer Patient Registry Software Market Share by Type (2018-2029)
  • Figure 26. Europe Cancer Patient Registry Software Market Share by Application (2018-2029)
  • Figure 27. Europe Cancer Patient Registry Software Market Share by Country (2018-2029)
  • Figure 28. Germany Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. France Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. U.K. Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Italy Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Russia Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Nordic Countries Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. China Cancer Patient Registry Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 35. China Cancer Patient Registry Software Market Share by Type (2018-2029)
  • Figure 36. China Cancer Patient Registry Software Market Share by Application (2018-2029)
  • Figure 37. Asia Cancer Patient Registry Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 38. Asia Cancer Patient Registry Software Market Share by Type (2018-2029)
  • Figure 39. Asia Cancer Patient Registry Software Market Share by Application (2018-2029)
  • Figure 40. Asia Cancer Patient Registry Software Market Share by Region (2018-2029)
  • Figure 41. Japan Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. South Korea Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. China Taiwan Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Southeast Asia Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. India Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Australia Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Size YoY (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Type (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Application (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America Cancer Patient Registry Software Market Share by Country (2018-2029)
  • Figure 51. Brazil Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Mexico Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Turkey Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Saudi Arabia Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Israel Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. GCC Countries Cancer Patient Registry Software Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Elekta Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 58. Electronic Registry Systems Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 59. C/Net Solutions Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 60. Rocky Mountain Cancer Data Systems Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 61. McKesson Corporation Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 62. Onco Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 63. Ordinal Data Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 64. Conduent Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 65. HimagineSolutions Revenue Growth Rate in Cancer Patient Registry Software Business (2018-2023)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!